ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
ID: ARPA-H-SN-25-127Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/229d3cd40bbe46d9892c4e2ea4090d79/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual event titled RAPID Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program focused on utilizing artificial intelligence (AI) and machine learning (ML) for precision diagnostics in rare diseases. This event will provide insights into the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, encouraging participation from patient advocacy groups to foster engagement and collaboration. The RAPID Program seeks to alleviate the diagnostic challenges faced by rare disease patients by developing innovative diagnostic tools and integrating comprehensive data, with registration for the event opening on December 19, 2024, and closing on February 21, 2025. Interested participants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.

    Point(s) of Contact
    RAPID Email Box
    RAPID@ARPA-H.gov
    Files
    Title
    Posted
    RAPID_PXP_Day_Special Notice_FINAL.pdf
    The Advanced Research Projects Agency for Health (ARPA-H) has announced a virtual Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program, which focuses on employing AI and ML for precision diagnostic solutions in rare diseases. The event will provide insights about the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, urging participation from patient advocacy groups. Registration for the event opens on December 19, 2024, and closes on February 21, 2025. The RAPID Program intends to end the diagnostic odyssey faced by rare disease patients by developing innovative diagnostic support tools and fostering comprehensive data integration. It will operate through several technical areas, including creating a massive rare disease dataset, leveraging novel diagnostic indicators, and developing a sustainable platform for AI diagnostic development. RAPID aims to democratize diagnostic access, ensuring benefits for underserved communities while promoting trust and engagement with patients throughout the research and diagnostic development process. This notice emphasizes participation in Patients’ Day as optional, with comprehensive details on PX Partner roles and program structure shared during the event.
    Similar Opportunities
    Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) titled "Rare Disease AI/ML for Precision Integrated Diagnostics" (RAPID). This initiative aims to enhance the diagnostic process for rare diseases by developing advanced diagnostic support tools and optimizing health data collection, particularly for underdiagnosed populations. The RAPID program is critical for addressing the prolonged diagnostic challenges faced by millions of rare disease patients, with a focus on creating comprehensive datasets and fostering collaborations for real-world validation of diagnostic models. Interested applicants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information, with the program spanning a proposed 4.5-year timeline and emphasizing equitable access to diagnostics.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing the ImagiNg Data EXchange (INDEX) program, aimed at enhancing access to medical imaging data for the development of artificial intelligence (AI) and machine learning (ML) algorithms in healthcare. The program seeks to establish a sustainable platform that connects data providers and users, focusing on business model development in its initial phase and system architecture in the subsequent phase. This initiative is crucial for facilitating cancer-related research and improving surgical procedures by ensuring efficient access to diverse medical imaging datasets. Interested proposers are encouraged to participate in a Proposers' Day on January 9, 2025, in Seattle, Washington, where they can learn more about the program and register for participation. For further inquiries, potential proposers can contact the INDEX Team at INDEX@arpa-h.gov.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the shortage of qualified radiologists and improve healthcare outcomes. This initiative is critical for advancing algorithm development and clinical studies by creating a comprehensive repository of diverse imaging datasets, including cancer digital pathology and surgical videos. Interested parties must submit their Solution Summary by January 28, 2025, with the full proposal due by March 27, 2025. For further inquiries, contact the INDEX Team at INDEX@arpa-h.gov.
    Real-World Application for Innovation and Development
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified small businesses to support its Real-World Application for Innovation and Development (RAPID) program, which aims to enhance regulatory processes through advanced data analytics and artificial intelligence. The primary objectives include the development and deployment of innovative prototypes, system maintenance, and the integration of advanced analytics into the regulatory framework to improve drug safety evaluations and regulatory reviews. This initiative is crucial for enabling FDA reviewers to efficiently access real-time data and analytics, particularly during public health events. Interested vendors must submit a capability statement by February 11, 2025, detailing their qualifications in relevant areas such as AI and cloud technologies, and can contact Noah Padilla at Noah.Padilla@fda.hhs.gov for further information.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing a Proposers' Day for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. This initiative aims to develop non-invasive diagnostic technologies for ocular and systemic conditions, particularly focusing on dry eye disease, through two primary technical areas: sensor technology for continuous biomarker monitoring and closed-loop therapeutic dosing systems. The Proposers' Day, scheduled for December 12, 2024, in Tampa Bay, Florida, will facilitate collaboration among participants and provide insights into the program's goals, with registration open from October 18, 2024, to December 5, 2024. Interested parties can contact OCULAB@ARPA-H.gov for further information and are encouraged to register for the event to enhance their proposal submissions.
    Emerging Health Innovators (EHI) Initiative
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Emerging Health Innovators (EHI) Initiative, aimed at fostering innovative biomedical solutions from early-career researchers and community-based organizations. This initiative invites submissions under two tracks: Technology-Driven Innovation and Community-Centered Innovation, with a focus on addressing significant gaps in health innovation and community health management. Proposals may seek funding up to $350,000 annually for a duration of two years, with a potential extension for a third year, and must adhere to strict compliance guidelines regarding research security, intellectual property, and human and animal subject research. Interested parties should contact the EHI Initiative Team at EHI@ARPA-H.gov, with proposals due by February 5, 2025, following a Proposers' Day on January 8, 2025.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    ADVANCING CLINICAL TRIALS READINESS (ACTR)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the Advanced Research Projects Agency for Health (ARPA-H), is hosting a hybrid Proposers’ Day for the Advancing Clinical Trials Readiness (ACTR) initiative. This event aims to gather insights and proposals that will enhance the readiness of clinical trials, focusing on innovative research and development in the health sector. The ACTR initiative is crucial for improving the efficiency and effectiveness of clinical trials, ultimately contributing to advancements in healthcare solutions. Interested parties can find registration details and additional information at the provided link, and inquiries can be directed to the ACTR Email Box at ACTR@ARPA-H.GOV.
    Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening. This initiative aims to develop innovative in silico human physiology modeling platforms that enhance drug safety assessments and reduce reliance on animal testing in preclinical studies, focusing on leveraging AI/ML for ADME-Tox simulations. The program is structured in two phases, with Phase I dedicated to developing predictive tools and Phase II aimed at integrating these tools into regulatory submissions for IND-enabling studies. Interested parties must submit a solution summary by November 25, 2024, and proposals by February 14, 2025, with all submissions made through the designated online platforms. For further inquiries, contact the CATALYST team via email at CATALYST@arpa-h.gov.